平滑肌肌動(dòng)蛋白α2(ACTa2)重組蛋白
Recombinant Actin Alpha 2, Smooth Muscle (ACTa2)
ACT-A2; ACTSA; ACTVS; Asma; GIG46; Cell growth-inhibiting gene 46 protein
- 編號(hào)RPB342Hu02
- 物種Homo sapiens (Human，人)相同的名稱(chēng)，不同的物種。
- 來(lái)源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測(cè)定)
- 亞細(xì)胞定位細(xì)胞質(zhì)
- 預(yù)測(cè)分子量45.5kDa
- 實(shí)際分子量46kDa(差異分析請(qǐng)參閱說(shuō)明書(shū))
- 片段與標(biāo)簽Cys2~Phe377 with N-terminal His Tag
- 緩沖液成份20mM Tris, 150mM NaCl緩沖液（pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300）
- 性狀凍干粉
- 純度> 95%
- 等電點(diǎn)5.0
- 應(yīng)用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請(qǐng)參見(jiàn)活性蛋白。 - 下載英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格10μg50μg200μg1mg5mg
- 價(jià)格¥ 864¥ 2160¥ 4320¥ 12960¥ 32400
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷(xiāo)商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
Figure. SDS-PAGE
通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月，-80°C不超過(guò)12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPB342Hu01 | 平滑肌肌動(dòng)蛋白α2(ACTa2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB342Hu02 | 平滑肌肌動(dòng)蛋白α2(ACTa2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| CPB342Hu21 | 平滑肌肌動(dòng)蛋白α2(ACTa2)卵白蛋白偶聯(lián)物 | Immunogen; SDS-PAGE; WB. |
| PAB342Hu01 | 平滑肌肌動(dòng)蛋白α2(ACTa2)多克隆抗體 | WB; IHC |
| CAB342Hu01 | 抗平滑肌肌動(dòng)蛋白α2(ACTa2)多克隆抗體 | WB; IHC |
| MAB342Hu22 | 平滑肌肌動(dòng)蛋白α2(ACTa2)單克隆抗體 | WB |
| MAB342Hu21 | 平滑肌肌動(dòng)蛋白α2(ACTa2)單克隆抗體 | WB; IHC; ICC; IP. |
| CAB342Hu22 | 抗平滑肌肌動(dòng)蛋白α2(ACTa2)單克隆抗體 | WB; IHC; ICC/IF |
| MAB342Hu29 | 平滑肌肌動(dòng)蛋白α2(ACTa2)單克隆抗體 | ICC/IF |
| MAB342Hu23 | 平滑肌肌動(dòng)蛋白α2(ACTa2)單克隆抗體 | ICC/IF |
| MAB342Hu24 | 平滑肌肌動(dòng)蛋白α2(ACTa2)單克隆抗體 | ICC/IF |
| MAB342Hu25 | 平滑肌肌動(dòng)蛋白α2(ACTa2)單克隆抗體 | ICC/IF |
| MAB342Hu27 | 平滑肌肌動(dòng)蛋白α2(ACTa2)單克隆抗體 | ICC/IF |
| FAB342Hu04 | 抗平滑肌肌動(dòng)蛋白α2(ACTa2)單克隆抗體 | FCM |
| FAB342Hu02 | 抗平滑肌肌動(dòng)蛋白α2(ACTa2)單克隆抗體 | FCM |
| FAB342Hu06 | 抗平滑肌肌動(dòng)蛋白α2(ACTa2)單克隆抗體 | FCM |
| FAB342Hu08 | 抗平滑肌肌動(dòng)蛋白α2(ACTa2)單克隆抗體 | FCM |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Cell Mol Immunol? | Toxoplasma gondii GRA15II effector-induced M1 cells ameliorate liver fibrosis in mice infected with Schistosomiasis japonica[Pubmed:27157496] |
| NAUNYN-SCHMIEDEBERGS?ARCHIVES OF?PHARMACOLOGY | Effects of repeated increasing doses of cisplatin as models of acute kidney injury and chronic kidney disease in rats[Pubmed: 32936352] |
| Brazilian Journal of Pharmaceutical Sciences | Hesperidin inhibits the epithelial to mesenchymal transition induced by transforming growth factor-β1 in A549 cells through Smad signaling in the cytoplasm[] |
| Structural Changes and Detection of Liver Fibrosis¨CRelated Protein Levels in Coculture of Alveolar Echinococcosis-Protoscoleces and Human Hepatic Stellate cells[] | |
| Parasit Vectors | Structural changes and expression of hepatic fibrosis-related proteins in coculture of Echinococcus multilocularis protoscoleces and human hepatic stellate?…[34857049] |
| Clinical and Translational Medicine | NOX5 mediates the crosstalk between tumor cells and cancer‐associated fibroblasts via regulating cytokine network[34459125] |